apoB48R Activators
apoB48R activators include compounds that could indirectly influence its activity through effects on lipid metabolism and transport. The first paragraph highlights compounds such as Fenofibrate, Niacin, and Omega-3 Fatty Acids, known for their roles in modulating lipid profiles and enhancing lipid transport, which could indirectly affect apoB48R's involvement in chylomicron metabolism.
The focus is on other compounds that impact cholesterol and lipid metabolism, including Rosuvastatin. Additionally, Pioglitazone, known for their roles in PPAR signaling, bile acid sequestration, and inhibition of lipid transfer proteins, are considered for their potential indirect influence on apoB48R. PCSK9 inhibitors like Berberine, are included for their roles in modulating cholesterol homeostasis, which could subsequently impact the functional activity of apoB48R.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Might enhance apoB48R function by altering lipid profiles and modulating lipid transport. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
A statin that influences cholesterol synthesis, potentially affecting apoB48R activity in lipid metabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
A PPARγ agonist, potentially affecting apoB48R function by influencing lipid metabolism and insulin sensitivity. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Influences lipid metabolism, potentially enhancing apoB48R activity through its effects on cholesterol and triglyceride levels. | ||||||